Strides Pharma gets USFDA inspection report for Alathur unit with no adverse observations

The company said the company's formulations unit in Alathur was inspected by the US Food and Drug Administration (USFDA) in August without any adverse observations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/31JjwVz
via IFTTT

0 comments:

Post a Comment